Evidence map›Paper›PMID 16545134›Full record

ArticleBMC cancer2006

Alternating current electrical stimulation enhanced chemotherapy: a novel strategy to bypass multidrug resistance in tumor cells.

Damir Janigro, Catalin Perju, Vincent Fazio, Kerri Hallene, Gabriele Dini, Mukesh K Agarwal, Luca Cucullo

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.5field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Synergistic effects of combined hyperthermia and electric fields treatment in non-small cell lung-cancer (NSCLC) cell lines.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Use of cold-atmospheric plasma in oncology: a concise systematic review.Therapeutic advances in medical oncology · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Damir JanigroDivision of Cerebrovascular Research, Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44106, USA. janigrd@ccf.org
Catalin Perju
Vincent Fazio
Kerri Hallene
Gabriele Dini
Mukesh K Agarwal
Luca Cucullo
Cleveland Clinic Lerner College of Medicine · US

Funding

MECHANISMS OF MULTIDRUG RESISTANCER01NS043284 · NINDS · CLEVELAND CLINIC LERNER COL/MED-CWRU · PI JANIGRO, DAMIR · 2002 to 2005
$1.3M
REGULATION OF CEREBRAL BLOOD FLOW BY ATPR01HL051614 · NHLBI · CLEVELAND CLINIC FOUNDATION · PI JANIGRO, DAMIR · 2000 to 2003
$1.2M
HETEROGENEITY OF HIPPOCAMPAL GLIAR01NS038195 · NINDS · UNIVERSITY OF WASHINGTON · PI JANIGRO, DAMIR · 1999 to 2002
$574k
NHLBI NIH HHS 2R01 HL51614NHLBI NIH HHS R01 HL051614NINDS NIH HHS R01 NS038195NINDS NIH HHS R01 NS043284NINDS NIH HHS R01 NS38195NINDS NIH HHS R01 NS43284
6 · The paper itself

Abstract

backgroundTumor burden can be pharmacologically controlled by inhibiting cell division and by direct, specific toxicity to the cancerous tissue. Unfortunately, tumors often develop intrinsic pharmacoresistance mediated by specialized drug extrusion mechanisms such as P-glycoprotein. As a consequence, malignant cells may become insensitive to various anti-cancer drugs. Recent studies have shown that low intensity very low frequency electrical stimulation by alternating current (AC) reduces the proliferation of different tumor cell lines by a mechanism affecting potassium channels while at intermediate frequencies interfere with cytoskeletal mechanisms of cell division. The aim of the present study is to test the hypothesis that permeability of several MDR1 over-expressing tumor cell lines to the chemotherapic agent doxorubicin is enhanced by low frequency, low intensity AC stimulation.

methodsWe grew human and rodent cells (C6, HT-1080, H-1299, SKOV-3 and PC-3) which over-expressed MDR1 in 24-well Petri dishes equipped with an array of stainless steel electrodes connected to a computer via a programmable I/O board. We used a dedicated program to generate and monitor the electrical stimulation protocol. Parallel cultures were exposed for 3 hours to increasing concentrations (1, 2, 4, and 8 microM) of doxorubicin following stimulation to 50 Hz AC (7.5 microA) or MDR1 inhibitor XR9576. Cell viability was assessed by determination of adenylate kinase (AK) release. The relationship between MDR1 expression and the intracellular accumulation of doxorubicin as well as the cellular distribution of MDR1 was investigated by computerized image analysis immunohistochemistry and Western blot techniques.

resultsBy the use of a variety of tumor cell lines, we show that low frequency, low intensity AC stimulation enhances chemotherapeutic efficacy. This effect was due to an altered expression of intrinsic cellular drug resistance mechanisms. Immunohistochemical, Western blot and fluorescence analysis revealed that AC not only decreases MDR1 expression but also changes its cellular distribution from the plasma membrane to the cytosol. These effects synergistically contributed to the loss of drug extrusion ability and increased chemo-sensitivity.

conclusionIn the present study, we demonstrate that low frequency, low intensity alternating current electrical stimulation drastically enhances chemotherapeutic efficacy in MDR1 drug resistant malignant tumors. This effect is due to an altered expression of intrinsic cellular drug resistance mechanisms. Our data strongly support a potential clinical application of electrical stimulation to enhance the efficacy of currently available chemotherapeutic protocols.

Indexed as

Drug Resistance, MultipleElectric Stimulation TherapyAnimalsAntineoplastic AgentsATP Binding Cassette Transporter, Subfamily B, Member 1DoxorubicinGenes, MDRHumansImmunohistochemistryNeoplasmsPermeabilityRatsTumor Cells, CulturedAntineoplastic AgentsATP Binding Cassette Transporter, Subfamily B, Member 1Doxorubicin

Identifiers

PMID16545134
PMCPMC1435916
OpenAlexW1962387000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.